Target intelligence / Profile preview

Progranulin mRNA 3' untranslated region miR-29b recognition element (GRN 3'UTR miR-29b MRE)

Target
GRN 3'UTR miR-29b MRE
Molecular classification
RNA, mRNA regulatory element, MicroRNA recognition element (MRE)
01

Overview

The Progranulin (GRN) mRNA 3' untranslated region (UTR) miR-29b recognition element is a conserved regulatory sequence located within the 3'UTR of the human GRN gene. This element is specifically recognized and bound by microRNA-29b (miR-29b), which acts as a negative regulator of progranulin expression by inducing translational repression and mRNA degradation (Jiao et al., 2010). In patients with frontotemporal dementia (FTD) caused by heterozygous GRN mutations, progranulin levels are reduced by approximately 50%, a condition known as haploinsufficiency. Targeting this recognition element with antisense oligonucleotides (ASOs) or target-site blockers (TSBs) provides a therapeutic strategy to increase progranulin production from the remaining healthy allele by sterically hindering miR-29b binding (Aggarwal et al., 2023). This mechanism effectively "derepresses" the mRNA, leading to enhanced translation and higher levels of secreted progranulin protein. Such interventions are currently being explored to treat FTD and other neurodegenerative conditions associated with progranulin deficiency.

Other names
GRN 3'UTR miR-29b binding siteProgranulin mRNA 3'UTR microRNA-29b target sequencemiR-29b MRE in GRNhPGRN 3'UTR miR-29b site
02

Mechanism of action

Steric blocking of microRNA binding to the mRNA 3'UTR to prevent translational repression and mRNA degradation, thereby increasing target protein levels.

03

Biological functions

Post-transcriptional regulationmRNA stabilityTranslational repressionProtein expression regulation
04

Disease associations

Frontotemporal dementia (FTD)Progranulin deficiencyNeurodegenerative diseaseAlzheimer's disease
05

Safety considerations

Off-target RNA bindingPotential oncogenic effects of progranulin over-expressionInflammatory response to oligonucleotide delivery
06

Interacting drugs

Antisense oligonucleotides (ASOs)

2 more in the full profile.

07

Biomarkers

Progranulin (PGRN) protein levels in cerebrospinal fluid (CSF)Progranulin (PGRN) protein levels in plasma

Beyond the preview

Go deeper on Progranulin mRNA 3' untranslated region miR-29b recognition element (GRN 3'UTR miR-29b MRE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progranulin mRNA 3' untranslated region miR-29b recognition element (GRN 3'UTR miR-29b MRE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call